Multiple sclerosis: experimental models and reality

Acta Neuropathologica

Volumn 133, Issue 2, 2017, Pages 223-244

  Lassmann, Hans ^a   Bradl, Monika ^a  

^a Medical University of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; CUPRIZONE; ETHIDIUM BROMIDE; FINGOLIMOD; LYSOPHOSPHATIDYLCHOLINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PERTUSSIS TOXIN; TOXIN; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CHRONIC DEMYELINATING ENCEPHALOMYELITIS; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CUPRIZONE-INDUCED DEMYELINATION; DEMYELINATING DISEASE; DEMYELINATION; ENCEPHALITIS; ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; INFLAMMATION; MULTIPLE SCLEROSIS; MURINE HEPATITIS VIRUS; NONHUMAN; PASSIVE TRANSPORT; PATHOGENESIS; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; SENSITIZATION; T LYMPHOCYTE; THEILER'S MURINE ENCEPHALOMYELITIS VIRUS; TISSUE INJURY; WHITE MATTER; ANIMAL; DISEASE MODEL;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MULTIPLE SCLEROSIS;

EID: 84991772094     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1631-4     Document Type: Review

References (169)

1. Alvord EC (1970) Acute disseminated encephalomyelitis and “allergic” neuroencephalopathies. In: Vinken PY, Bruyn GW (eds) Handbook of clinical neurology, vol 9. Elsevier, New York, pp 500–571
2. + T and B cells. J Immunol 188:2084–2092
3. Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds RA, Franklin RJ, Giovannoni G, Compston DA, Baker D, Spillantini MG, Chandran S (2008) Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 131:1736–1748
4. Ascherio A, Munger KL (2016) Epidemiology of multiple sclerosis. From risk factor to prevention—an update. Semin Neurol 36:103–114
5. Bailey OT, Pappenheimer AM, Sargent F, Cheever MD, Daniels JB (1949) A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. J Exp Med 90:195–212
6. Baker D, Amor S (2012) Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis. J Neuroimmunol 242:78–83
7. Baker D, O’Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL (1990) Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol 28:261–270
8. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458–468
9. Bartholomäus I, Kawakami N, Odoardi F, Schläger C, Miljkovic D, Ellwart JW, Klinkert WE, Flügel-Koch C, Issekutz TB, Wekerle H, Flügel A (2009) Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462:94–98
10. Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL (2008) Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest 118:1532–1543
11. Baxter AG, Hodgkin PD (2002) Activation rules: the two-signal theories of immune activation. Nat Rev Immunol 2:439–446
12. Ben Nun A, Kaushnasky N, Kawakami N, Krishnamoorthy G, Berer K, Liblau R, Hohlfeld R, Wekerle H (2014) From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development. J Autoimmun 54:33–50
13. Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11:195–199
14. Bender SJ, Weiss SR (2010) Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol 5:336–354
15. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:538–541
16. Bernard CC (1976) Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J Immunogenet 3:263–274
17. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197:1073–1081
18. Bettelli E, Baeten D, Jäger A, Sobel RA, Kuchroo VK (2006) Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116:2393–2402
19. Bieber AJ, Ure DR, Rodriguez M (2005) Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J Neuropath Exp Neurol 64:46–57
20. Billiau A, Matthys P (2001) Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases. J Leukocyte Biol 70:849–860
21. Blakemore WF (1982) Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropath Appl Neurobiol 8:365–375
22. Blanc CA, Rosen H, Lane TE (2014) FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination. J Neuroinflammation 11:138
23. Blauth K, Soltys J, Matschulat A, Reiter CR, Ritchie A, Baird NLO, Bennett JL, Owens GP (2015) Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants. Acta Neuropathol 130:765–781
24. Booss J, Esiri MM, Tourtellotte WW, Mason DY (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62:219–232
25. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66:630–643
26. Brosnan CF, Raine CS (2013) The astrocyte in multiple sclerosis revisited. Glia 61:453–465
27. Cabarrocas J, Bauer J, Piaggio E, Liblau R, Lassmann H (2003) Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol 33:1174–1182
28. Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DF (2010) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481–492
29. + T regulatory cells. Eur J Immunol 36:671–680
30. Crawford AH, Chambers C, Franklin RJ (2013) Remyelination: the true regeneration of the central nervous system. J Comp Pathol 149:242–254
31. Crawford AH, Tripathi RB, Richardson WD, Franklin RJ (2016) Developmental origin of oligodendrocyte lineage cells determines response to demyelination and susceptibility to age-associated functional decline. Cell Rep S2211–S47. doi:10.1016/j.celrep.2016.03.069
32. Cross AH, McCarron R, McFarlin DE, Raine CS (1987) Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection. Lab Invest 57:499–512
33. Croxford JL, Ercolini AM, Degutes M, Miller SD (2006) Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus. Eur J Immunol 36:2671–2680
34. Dandekar AA, Anghelina D, Perlman S (2004) Bystander CD8 T-cell-mediated demyelination is interferon-gamma-dependent in a coronavirus model of multiple sclerosis. Am J Pathol 164:363–369
35. Dandekar AA, Perlman S (2002) Virus induced demyelination in nude mice is mediated by gamma delta T cells. Am J Pathol 161:1255–1263
36. Dandekar AA, Wu GF, Pewe L, Perlman S (2001) Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J Virol 75:6115–6120
37. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, Pirko I (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology 18:21–29
38. Desai RA, Davies AL, Tachrount M, Kasti M, Laulund F, Golay X, Smith KJ (2016) Cause and prevention of demyelination in a model of multiple sclerosis. Ann Neurol 79:591–604
39. Dörries R, Watanabe R, Wege H, ter Meulen V (1986) Murine coronavirus-induced encephalomyelitis in rats: analysis of immunoglobulins and virus-specific antibodies in serum and cerebrospinal fluid. J Neuroimmunol 12:131–142
40. Doucette JR, Jiao R, Nazarali AJ (2010) Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice. Cell Mol Neurobiol 30:607–629
41. Dumas A, Amiable N, de Rivero Vaccari JP, Chae JJ, Keane RW, Lacroix S, Vallieres L (2014) The inflammosome pyrin contributes to pertussis toxin-induced Il-1ß synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis. PLoS Pathog 10:1004150
42. Ellmerich S, Takacs K, Mycko M, Waldner H, Wahid F, Boyton RJ, Smith PA, Amor S, Baker D, Hafler DA, Kuchroo VK, Altmann DM (2004) Disease related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur J Immunol 34:1839–1848
43. Felts PA, Woolston AM, Fernando HB, Asquith S, Gregson NA, Mizzi OJ, Smith KJ (2005) Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128:1649–1666
44. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393–399
45. Fischer MT, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T, Hametner S, Mahad D, Binder CJ, Krumbholz M, Bauer J, Bradl M, Lassmann H (2013) Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136:1799–1815
46. Flügel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H (2001) Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547–560
47. Fog T (1950) Topographic distribution of plaques in the spinal cord in multiple sclerosis. A.M.A. Arch Neurol Psychiat 63:382–414
48. Franklin RJ, Thao C, Sim FJ (2002) Ageing and CNS remyelination. NeuroReport 13:923–928
49. Franklin RJM, ffrench-Constant C, Edgar J, Smith JM (2012) Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol 8:624–634
50. Franklin RJM, Gallo V (2014) The translational biology of remyelination: past, present and future. Glia 62:1905–1915
51. + T cells in multiple sclerosis. Nat Med 14:1227–1235
52. Frischer J, Weigand S, Guo Y, Kale N, Parisi J, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti C (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78:710–721
53. Frischer JM, Bramow S, Dal Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175–1189
54. Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds T (2013) Cortical grey matter demylination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats. Brain 136:3596–3608
55. Gilli F, Li L, Campbell SJ, Anthony DC, Pachner AR (2015) The effect of B-cell depletion in the Theiler’s model of multiple sclerosis. J Neurol Sci 359:40–47
56. Gudi V, Gingele S, Skripuletz T, Stangel M (2014) Glial response during cuprizone-induced de- and remyelination in the CNS. Front Cell Neurosci 8:73
57. Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, Grabner G, Trattnig S, Pfeifenbring S, Brück W, Lassmann H (2016) The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139:807–815
58. Hall SM (1972) The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 10:535–546
59. Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848–861
60. Hampton DW, Serio A, Pryce G, Al-Izki S, Franklin JM, Giovannoni G, Baker D, Chandran S (2013) Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis. Acta Neuropath Commun 1:84
61. Hauser SL (2015) The Charcot lecture/beating MS: a story of B cells, with twists and turns. Mult Scler J 21:8–21
62. Hayashi T, Morimoto C, Burks JS, Kerr C, Hauser SL (1988) Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens. Ann Neurol 24:523–531
63. Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK (1998) Microglia/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38–49
64. Höftberger R, Leisser M, Bauer J, Lassmann H (2015) Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis? Acta Neuropathol Commun 3:80
65. Homberger FR, Zhang L, Barthold SW (1998) Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci 48:50–54
66. Houtman JJ, Fleming JO (1996) Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol 2:361–376
67. Howe CL, Adelson JD, Rodriguez M (2007) Absence of perforin expression confers axonal protection despite demyelination. Neurobiol Dis 25:354–359
68. Huizinga R, Heijmans N, Schubert P, Gschmeissner S, t Hart BA, Herrmann H, Amor S (2007) Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J Neuropath Exp Neurol 66:295–304
69. Huizinga R, Gerritsen W, Heijmans N, Amor S (2008) Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis 32:461–470
70. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J (2001) A pathogenic role for myelin specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194:669–676
71. Ikota H, Iwasaki A, Kawarai M, Nakazato Y (2010) Neuromyelitis optica with intraspinal expansion of Schwann cell remyelination. Neuropathology 30:427–433
72. International Multiple Sclerosis Genetics Consortium (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45:1353–1360
73. Jagessar S, Heijmans N, Blezer E, Bauer J, Weissert R, ‘t Hart B (2015) Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant. J Neuroinflamm 12:169
74. Jeffery ND, Blakemoore WF (1995) Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24:775–781
75. Kabat EA, Wolf A, Bezer AE, Murray JP (1951) Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. J Exp Med 93:615–633
76. Kamradt T, Soloway PD, Perkins DL, Gefter ML (1991) Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein. J Immunol 147:3296–3302
77. Kawakami N, Nägerl UV, Odoardi F, Bonhoeffer T. Wekerle H, Flügel A (2005) Live imaging of effector cell trafficking and autoantigen recognition within unfolding autoimmune encephalomyelitis lesions. J Exp Med 201:1805–1814
78. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK (2006) Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21:626–632
79. Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P (2015) Antibodies to MOG in adults with inflammatory demyelinating disease. Neurol Neuroimmunol Neuroinflamm 2:e163
80. Kim TS, Perlman S (2005) Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus. Am J Path 166:801–810
81. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267–276
82. Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJ (2001) Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35:204–212
83. Krishnamoorthy G, Lassmann H, Wekerle H, Holz A (2006) Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest 116:2385–2392
84. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H (2009) Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med 15:626–632
85. Kurosawa K, Misu T, Takai Y, Sato DK, Takahashi T, Abe Y, Iwanari H, Ogawa R, Nakashima I, Fujihara K, Hamakubo T, Yasui M, Aoki M (2015) Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathol Commun 3:82
86. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705–2712
87. Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Brück W, Rauschka H, Schmidbauer M, Lassmann H (2007) Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 17:38–44
88. Lampert PW, Sims JK, Kniazeff AJ (1973) Mechanisms of demyelination in JHM virus encephalomyelitis. Acta Neuropathol 24:76–85
89. Lassmann H, Wisniewski HM (1979) Chronic relapsing experimental allergic encephalomyelitis: clinico-pathological comparison with multiple sclerosis. Arch Neurol 36:490–497
90. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75:566–576
91. Lassmann H, Brück W, Lucchinetti C (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218
92. Levine S (1960) Localization of allergic encephalomyelitis in lesions of cyanide encephalopathy. J Neuropath Exp Neurol 19:238–247
93. Levine S, Hoenig EM (1968) Induced localization of allergic adrenalitis and encephalomyelitis at sites of thermal injury. J Immunol 100:1310–1318
94. Levy H, Assaf D, Frenkel D (2010) Characterization of brain lesions in a mouse model of progressive multiple sclerosis. Exp Neurol 226:148–158
95. Levy Barazany H, Barazany D, Puckett L, Blanga-Kanfi S, Borenstein-Auerbach N, Yang K, Peron JP, Weiner HL, Frenkel D (2014) Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE. Exp Neurol 255:63–70
96. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443–454
97. Lipton HL, Twaddle G, Jelachich ML (1995) The predominant virus antigen burden is in macrophages in Theiler’s murine encephalomyelitis virus-induced demyelinating disease. J Virol 69:2525–2533
98. Lisak RP, Benjamins JA, Nedelkoska L, Barger JL, Ragheb S, Fan B, Ouamara N, Johnson TA, Rajasekharan S, Bar-Or A (2012) Secretory products of multiple sclerosis B-cells are cytotoxic to oligodendrocytes in vitro. J Neuroimmunol 246:85–95
99. Lu C, Pelech S, Zhang H, Bond J, Spach K, Noubade R, Blanjenhorn EP, Teuscher C (2008) Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J Neurosci Res 86:2624–2640
100. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–911
101. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365:2188–2197
102. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R (2010) A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68:477–493
103. Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183–193
104. Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131:1722–1735
105. Manrique-Hoyos N, Jürgens T, Gronborg M, Kreutzfeldt M, Schedensack M, Kuhlmann T, Schrick C, Brück W, Urlaub H, Simons M, Merkler D (2012) Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis. Ann Neurol 71:227–244
106. Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130:2800–2815
107. Mars LT, Bauer J, Gross DA, Bucciarelli F, Firat H, Hudrisier D, Lemonnier F, Kosmatopoulos K, Liblau RS (2007) CD8 T cell response to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol 179:5090–5098
108. Martinez NE, Karlsson F, Sato F, Kawai E, Omura S, Minagar A, Grisham MB, Tsunoda I (2014) Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis. Brain Pathol 24:436–451
109. Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C (2007) Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 204:2363–2372
110. Matsushima GK, Morell P (2001) The neurotoxicant cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107–116
111. Mendel I, Kerlero de Rosbo N, Ben Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic cells. Eur J Immunol 25:1951–1959
112. Merkler D, Ernsting T, Kerschensteiner M, Brück W, Stadelmann C (2006) A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129:1972–1983
113. Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, Trapp BD, Ransohoff RM (2008) Cortical demyelination in PML and MS: similarities and differences. Neurology 70:336–343
114. Monteyne P, Bureau JF, Brahic M (1997) The infection of mouse by Theiler’s virus: from genetics to immunology. Immunol Rev 159:163–176
115. Mues M, Bartholomäus I, Thestrup T, Griesbeck O, Wekerle H, Kawakami N, Krishnamoorthy G (2013) Real-time in vivo analysis of T cell activation in the central nervous system using genetically encoded calcium indicator. Nat Med 19:778–783
116. Na SY, Cao Y, Toben C, Nitschke L, Stadelmann C, Gold R, Schimpl A, Hünig T (2008) Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 131:2353–2365
117. + T cells. Immunity 37:134–146
118. Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Brück W, Bishop D, Misgeld T, Kerschensteiner M (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495–499
119. Njenga MK, Coenen MJ, DeCuir N, Yeh HY, Rodriguez M (2000) Short term treatment with interferon-alpha/beta promotes remyelination, whereas long term treatment aggravates demyelination in a murine model of multiple sclerosis. J Neurosci Res 59:661–670
120. Nexo BA, Jensen SB, Nissen KK, Hansen B, Laska MJ (2016) Two endogenous retroviral loci appear to contribute to multiple sclerosis. BMC Neurol 16:57
121. Olson JK, Eagar TN, Miller SD (2002) Functional activation of myelin-specific T cells by virus-induced molecular mimicry. J Immunol 169:2719–2726
122. Pachner AR, Li L, Lagunoff D (2011) Plasma cells in the central nervous system in the Theiler’s virus model of multiple sclerosis. J Neuroimmunol 232:35–40
123. Paterson PY (1960) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119–135
124. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego
125. Peferoen LAN, Breur M, van de Berg S, Peferoen-Baert R, Boddeke EHWGM, van der Valk P, Pryce G, van Noort JM, Baker D, Amor S (2016) Ageing and recurrent episodes of neuroinflammation promote progressive EAE in Biozzi mice. Immunology 149:146–156
126. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, Wucherpfennig K, Turley S, Carroll MC, Sobel RA, Bettelli E, Kuchroo VK (2011) Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35:986–996
127. Pierson E, Simmons SB, Castelli L, Goverman JM (2012) Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev 248:205–215
128. Pirko I, Johnson AJ (2008) Neuroimaging of demyelination and remyelination models. Curr Top Microbiol Immunol 318:241–266
129. Pohl M, Kawakami N, Kitic M, Bauer J, Martins R, Fischer MT, Machado-Santos J, Mader S, Ellwart JW, Misu T, Fujihara K, Wekerle H, Reindl M, Lassmann H, Bradl M (2013) T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol Commun 1:85
130. Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R, Domingues HS, Holz A, Kurschus FC, Wekerle H (2009) Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG reactive transgenic T cells recruit endogeneous MOG-specific B cells. J Exp Med 206:1303–1316
131. Pomeroy IM, Matthews PM, Frank JA, Jordan EK, Esiri MM (2005) Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 128:2713–2721
132. Praet J, Guglielmetti C, Berneman Z, Van der Linden A, Ponsaerts P (2014) Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Behav Rev 47:485–505
133. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F (2009) C-C chemokine receptor-6 regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the induction of EAE. Nat Immunol 10:514–523
134. Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M (1998) Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 4:187–193
135. Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39–53
136. Rodriguez M, Leibowitz JL, Lampert PW (1983) Persistent infection of oligodendrocytes in Theiler’s virus-induced encephalomyelitis. Ann Neurol 13:426–433
137. Rodriguez M, Oleszak E, Leibowitz J (1987) Theiler’s murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 7:325–365
138. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349–361
139. Saadoun S, Waters P, Owens GP, Bennett JL, Vincent A, Papadopoulos MC (2014) Neuromyelitis optica MOG-IgG causes reversible lesions in the mouse brain. Acta Neuropath Commun 2:35
140. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, Desbois S, Waisman A, Lassmann H, Liblau RS, Mars LT (2008) Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol 181:1617–1621
141. Scalfari A, Neuhaus A, Daumer M, Ebers GC, Muraro PA (2011) Age and disability accumulation in multiple sclerosis. Neurology 77:1246–1252
142. Scheikl T, Pugnolet B, Dalard C, Desbois S, Raison D, Yamazaki M, Saoudi A, Bauer J, Lassmann H, Hardin-Bouzet H, Liblau RS (2012) Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus. J Immunol 188:4731–4735
143. Scheld M, Rüther BJ, Große-Veldmann R, Ohl K, Tenbrock K, Dreymüller D, Fallier-Becker P, Zendedel A, Beyer C, Clarner T, Kipp M (2016) Neurodegeneration triggers peripheral immune cell recruitment into the forebrain. J Neurosci 36:1410–1415
144. Schuh C, Wimmer I, Hametner S, Haider L, Van Dam AM, Liblau RS, Smith KJ, Probert L, Binder CJ, Bauer J, Bradl M, Mahad D, Lassmann H (2014) Oxidative injury in multiple scerosis is only partly reflected in experimental disease models. Acta Neuropathol 128:247–266
145. Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH (2008) Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study”. Lancet Neurol 7:796–804
146. Seitelberger F, Jellinger K, Tschabitscher H (1958) Zur Genese der akuten Entmarkungsencephalitis. Wien Klein Wschr 70:453–459
147. Sepulveda M, Amangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, Tellez N, Midaglia L, Arino H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A (2016) Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol 263:1349–1360
148. Sharma R, Fischer MT, Bauer J, Felts PA, Smith KJ, Misu T, Fujihara K, Bradl M, Lassmann H (2010) Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol 120:223–236
149. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casacchia-Bonnefil P (2008) Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11:1024–1034
150. Singer BA (2016) Parental treatment of multiple sclerosis: the advent of monoclonal antbodies. Semin Neurol 36:140–147
151. Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D (2009) Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci 29:14965–14979
152. Steinman L, Zamvill SS (2016) Beginning of the end of two-stage theory purporting inflammation then degeneration explains pathogenesis of progressive multiple sclerosis. Curr Opin Neurol 29:340–344
153. Stohlman SA, Hinton DR (2001) Viral induced demyelination. Brain Pathol 11:92–106
154. Stohlman SA, Weiner LP (1981) Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31:38–44
155. Storch MK, Bauer J, Linington C, Olsson T, Weissert R, Lassmann H (2006) Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatability complex (MHC) haplotype-related. J Neuropathol Exp Neurol 65:1137–1142
156. Storch MK, Stefferl A, Brehm U, Weissert R, Wallström E, Kerschensteiner M, Olsson T, Linington C, Lassmann H (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8:681–694
157. Stuart G, Krikorian KS (1928) The neuro-paralytic accidents of anti-rabies treatment. Ann Trop Med Parasitol 22:327–377
158. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166:7579–7587
159. Tabira T, Itoyama I, Kuroiwa Y (1984) The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in guinea pigs. Prog Clin Biol Res 146:43–48
160. Uchimura I, Shiraki H (1957) A contribution to the classification and the pathogenesis of demyelinating encephalomyelitis. J Neuropathol Exp Neurol 16:139–203
161. Van Oosten BW, Lai M, Hodgkinson S, Barkhof F, Miller DH, Moseley IF, Thompson AJ, Rudge P, Mc Dougall A, McLeod JG, Ader HJ, Polman CH (1997) Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double blind, placebo-controlled MR-monitored phase II trial. Neurology 49:351–357
162. Vass K, Heininger K, Schäfer B, Linington C, Lassmann H (1992) Interferon-gamma potentiates antibody mediated demyelination in vivo. Ann Neurol 32:198–206
163. Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD (2013) Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflamm 10:35
164. Watanabe R, Wege H, ter Meulen V (1983) Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305:150–153
165. Weissert R, Wallström E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T (1998) MHC haplotype dependent regulation of MOG-induced EAE in rats. J Clin Invest 102:1265–1273
166. Wekerle H, Kojima K, Lannes Vieira J, Lassmann H, Linington C (1994) Animal models. Ann Neurol Suppl S47–S53
167. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9:271–277
168. Wu GF, Perlman S (1999) Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 73:8771–8780
169. Zeka B, Hastermann M, Hochmeister S, Kögl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato DK, Nakashima I, Reindl M, Lassmann H, Bradl M (2015) Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathol 130:783–798